TrialCerebellum (London, England)2013

Triple therapy with darbepoetin alfa, idebenone, and riboflavin in Friedreich's ataxia: an open-label trial.

Javier Arpa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.